cancers-logo

Journal Browser

Journal Browser

Announcements

18 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Cancer Immunology and Immunotherapy” Section


We are delighted to share some highly cited Special Issues in 2024 from the “Cancer Immunology and Immunotherapy” Section of Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

Inflammation, Immunity, and Cancer Progression
Guest Editors: Dr. Deepak Parashar, Dr. Vivek K. Kashyap and Dr. Subhash Tripathi
Submission deadline: 31 May 2024

PD-1/PD-L1 Immune Checkpoint Therapy: From Predictive Biomarkers to Noninvasive Imaging
Guest Editors: Prof. Dr. Patrizia Ferroni, Prof. Dr. Fiorella Guadagni and Prof. Dr. Mario Roselli
Submission deadline: 25 April 2024

Role of Immune Checkpoint Inhibitors or Targeted Therapy in the Treatment of Patients with Melanoma Volume II
Guest Editors: Dr. Henrik Schmidt and Dr. Eva Ellebæk
Submission deadline: 20 September 2024

Near-Infrared Photoimmunotherapy for Cancer Treatment
Guest Editor: Dr. Hisataka Kobayashi
Submission deadline: 10 April 2024

Macrophage-Directed Cancer Immunotherapy
Guest Editor: Dr. Zahra Payandeh
Submission deadline: 31 December 2024

State-of-the-Art Cancer Immunology and Immunotherapy in the USA
Guest Editors: Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante
Submission deadline: 20 June 2024

We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

18 July 2025
Welcoming New Editorial Board Members of Cancers Joined in July 2025


We are pleased to announce that six new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in July 2025. We wish our new members success in both their research and their efforts to develop the journal.

Name Affiliation
Dr. John Inge Johnsen Karolinska Institutet, Sweden
Dr. Ji Young Yoo University of Texas Health Science, USA
Dr. Joel S Brown Moffitt Cancer Center, USA
Dr. Sushant K. Kachhap Johns Hopkins University School of Medicine, USA
Dr. Niels Ødum University of Copenhagen, Denmark
Prof. Dr. Hsian-Rong Tseng University of California, USA

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

  • A full academic CV;
  • A short cover letter that details your interest in the position.

17 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Cancer Survivorship and Quality of Life” Section


We are delighted to share some highly cited Special Issues in 2024 in the “Cancer Survivorship and Quality of Life” Section in Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

Supportive Care for Patients with Cancer
Guest Editor: Prof. Dr. Andrew Davies
Viewed by: 49330+
Latest Advancements in Health-Related Quality of Life Research in Cancer Survivorship
Guest Editors: Prof. Dr. Thomas Licht and Prof. Dr. Richard Crevenna
Viewed by: 33540+
Advances in Supportive and Palliative Care in Cancer
Guest Editor: Prof. Dr. Sriram Yennurajalingam
Viewed by: 25120+
Medical Complications and Supportive Care in Patients with Cancer
Guest Editor: Dr. Javier Marco-Hernández
Viewed by: 18810+
Advanced Strategies in the Care of Hepatocellular Carcinoma Patients
Guest Editors: Prof. Dr. Matteo Donadon and Prof. Dr. Guido Torzilli
Viewed by: 20590+
Cancer Pain: From Basic Research to Drug Discovery and Clinical Studies
Guest Editors: Dr. Arpad Szallasi, Prof. Dr. Gabriela Trevisan and Dr. Andreea Dumele
Viewed by: 17040+

We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

17 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Transplant Oncology” Section


We are delighted to share some highly cited Special Issues in 2024 in the “Transplant Oncology” Section in Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below.

Advances and Future Developments in Liver Transplantation for Cancers
Guest Editors: Dr. Nicolas Golse, Dr. Giammauro Berardi, Dr. François Cauchy and Dr. Takashi Kokudo
Viewed by: 12025+

Liver Transplantation for Liver Malignancies: Pushing the Limits Further
Guest Editor: Prof. Dr. Long-Bin Jeng
Viewed by: 4145+

Lung Transplantation and Lung Cancer: Clinical Scenarios, Outcomes and Future Perspectives
Guest Editors: Dr. Andrea Dell'Amore, Dr. Eleonora Faccioli and Dr. Alessio Campisi
Viewed by: 10280+

Liver Transplantation for Hepatocellular Carcinoma
Guest Editors: Prof. Dr. Daniel Cherqui and Prof. Dr. Olivier Rosmorduc
Viewed by: 6755+

Liver Transplantation for Cancer: The Future of Transplant Oncology
Guest Editor: Prof. Dr. Tomoharu Yoshizumi
Viewed by: 4050+

We invite you to read and submit relevant papers to the journal Cancers using the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

16 July 2025
Meet Us at the ESMO Congress 2025, 17–21 October 2025, Berlin, Germany


The ESMO Congress is a significant global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2025 aims to converge groundbreaking discoveries, innovative treatments and collaborative approaches to shape the future of cancer care. This event provides the opportunity to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals who are advancing diagnosis, treatment and survivorship in this field.

The following MDPI journals will be represented at this conference:

If you are planning to attend the above conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #P2007 and answering any questions that you may have.

For more information about this conference, please visit the following website: https://www.esmo.org/meeting-calendar/esmo-congress-2025.

15 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Cancer Informatics and Big Data” Section


We are delighted to share some highly cited Special Issues in 2024 from the “Methods and Technologies Development” Section of Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

The Use of Real World (RW) Data in Oncology
Guest Editor: Dr. Christopher T. Wilke
Submission deadline: 31 August 2024
Computational Studies of Mutagenic Processes in Cancer
Guest Editors: Dr. Teresa M. Przytycka and Dr. Damian Wójtowicz
Submission deadline: 15 December 2024
Artificial Intelligence in Cancer Research: Knowledge Representation and Data Perspectives
Guest Editors: Dr. Catia Pesquita and Dr. Andreas Schlicker
Submission deadline: 15 August 2024 
Advances in Cancer Data and Statistics
Guest Editor: Prof. Dr. Vesna Zadnik  
Submission deadline: 30 December 2024
Novel Insights in Acute Lymphoblastic and Myeloblastic Leukemia
Guest Editor: Dr. María Hernández Valladares
Submission deadline: 29 February 2024
Computational Pathology for Breast Cancer and Gynecologic Cancer
Guest Editor: Prof. Dr. Ching-Wei Wang
Submission deadline: 31 March 2024

We invite you to read and submit relevant papers to the journal Cancers using the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

15 July 2025
Cancers | Highly Cited Special Issues Published in 2024 in the “Molecular Cancer Biology” Section


Cancers (ISSN: 2072-6694) is an open access journal, granting its readers free and unlimited access to all full-text articles. We welcome you to read the following highly cited Special Issues published in 2024 (now closed for submissions) in the “Molecular Cancer Biology” Section: 

1. “Autologous Stem Cell Transplantation or New Cellular Therapies for Neoplasias
Guest Editor: Prof. Dr. Gabriela Maria Baerlocher
Views: 27880+

2. “Liver Cancers Molecular Biomarkers Predicting Outcome
Guest Editor: Dr. Nima Kokabi
Views: 37870+

3. “2nd Edition: Estrogen Receptor-Positive (ER+) Breast Cancers
Guest Editors: Prof. Dr. Christos Papadimitriou, Dr. Angelos Koutras and Dr. Eleni Timotheadou
Views: 27660+

4. “Gastric Cancers: Molecular Mechanisms, Novel Targets and Immunotherapies: From Bench to Clinical Therapeutics
Guest Editors: Prof. Dr. Jaffer A. Ajani and Prof. Dr. Shumei Song
Views: 20590+

5. “Drug Repurposing and Reformulation for Cancer Treatment
Guest Editors: Prof. Dr. Dhimant Desai, Prof. Dr. Arati Sharma and Dr. Abhijit Date
Views: 34640+

6. “Combined Hepatocellular-Cholangiocarcinoma: An Update on Epidemiology, Classification, Diagnosis and Management
Guest Editor: Prof. Dr. Marcus Bahra
Views: 24470+

15 July 2025
Cancers | Highly Cited Special Issues Published in 2024 in the “Cancer Pathophysiology” Section


We are pleased to invite you to read the highly cited Special Issues in 2024 related to the “Cancer Pathophysiology” Section in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant Special Issues is provided below:

Pathology of Urogenital Cancers
Guest Editors: Prof. Roberta Mazzucchelli and Dr. Giovanni Tossetta
Cited by 140+
Viewed by 36000+

Metastatic Progression of Human Melanoma
Guest Editors: Prof. Dr. Jozsef Tímar and Dr. Andrea Ladányi
Cited by 120+
Viewed by 55000+

The Role of Tunneling Nanotubes in Intercellular Communication and Pathophysiology of Cancer
Guest Editor: Dr. Emil Lou
Cited by 110+
Viewed by 31000+

New Insights in Molecular Pathology of Cancers: From Biomarkers to Therapeutic Targets
Guest Editor: Dr. Hisham Bahmad
Cited by 60+
Viewed by 22000+

Advances in Breast Cancer: From Pathogenesis to Therapy
Guest Editors: Prof. Dr. Ana Isabel Torres-Suárez and Dr. Ana Isabel Fraguas-Sánchez
Cited by 35+
Viewed by 16000+

Lipids and Small Metabolites in Cancer
Guest Editors: Dr. Zsolt Balogi and Dr. Laszlo Vigh
Cited by 30+
Viewed by 20000+

15 July 2025
Cancers | Highly Cited Special Issues in 2024 in the “Methods and Technologies Development” Section


We are delighted to share some highly cited Special Issues in 2024 from the “Methods and Technologies Development” Section of Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

Recent Trends in PET/CT Tracer Development and Multimodal Imaging

Guest Editors: Prof. Dr. Olaf Prante and Prof. Dr. Tobias Bäuerle

Submission deadline: 30 June 2024

 “Radionuclide Therapy and Hybrid Imaging in   Oncology

Guest Editors: Dr. Amir Sabet and Prof. Dr. Frank Grünwald

Submission deadline: 29 February 2024

New Precision Medicine Approaches in Haematological Malignancies: Novel Targets and Advanced Therapies

Guest Editors: Dr. Ilaria Stefania Pagani, Dr. Hannah Wardill and Dr. Teresa Sadras

Submission deadline: 31 January 2024

 “The Role of PET Imaging in Oncology: New Advancements in Clinical and Research Setting

Guest Editors: Dr. Pierpaolo Alongi and Dr. Desiree Deandreis

Submission deadline: 31 March 2024

Updates on Imaging of Common Urogenital Neoplasms

Guest Editor: Dr. Athina C Tsili

Submission deadline: 29 February 2024

 “Recent Advances and Challenges in Breast Cancer Surgery

Guest Editor: Dr. Antonio Piñero-Madrona

Submission deadline: 30 April 2024

We invite you to read and submit relevant papers to the journal Cancers using the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

14 July 2025
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026


We cordially invite you to attend the 1st International Online Conference on Hematology organized by the MDPI journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0), and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2). It will take place online from 28 to 30 October 2026, and it is free of charge for all participants.

Conference Chair:

  • Prof. Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

The topics of interest:

S1. Multiple Myeloma;
S2. Acute Myeloid Leukemia;
S3. Acute Lymphoblastic Leukemia;
S4. Non-Hodgkin Lymphoma;
S5. Hodgkin Lymphoma;
S6. CML and Myeloproliferative Neoplasms;
S7. Stem Cell Transplantation and New Cellular Therapies;
S8. Rare diseases.

Important dates:
Deadline for abstract submission:
29 June 2026;
Notification of acceptance: 28 July 2026;
Deadline for registration: 22 November 2026.

Guide for authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1493.

To register for the event, please click on the following link: https://sciforum.net/event/IOCHE2026?subscribe&section=#registration.

Note: We only accept abstracts for this conference. To publish a conference proceedings paper for free and submit a full manuscript to the organizing journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0) and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2), please refer to the Publication Opportunities section.

Best Presentation Award and Best Poster Award:

  • Six winners;
  • Each winner will receive a certificate;
  • CHF 200 each.

For any enquiries regarding this event, please contact ioche2026@mdpi.com.

We look forward to seeing you at the 1st International Online Conference on Hematology!

Back to TopTop